Amwill Health Care Ltd
Incorporated in 2009, Amwill Health Care is in the wholesale trading of pharmaceutical products[1]
- Market Cap ₹ Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E
- Book Value ₹
- Dividend Yield %
- ROCE %
- ROE %
- Face Value ₹
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Healthcare Healthcare Pharmaceuticals & Biotechnology Pharmaceuticals
Quarterly Results
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Figures in Rs. Crores
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Dividend Payout % |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Equity Capital |
| Reserves |
| Total Liabilities |
| CWIP |
| Investments |
| Total Assets |
Cash Flows
Figures in Rs. Crores
| Net Cash Flow |
| Free Cash Flow |
| CFO/OP |
Ratios
| Debtor Days |
| Inventory Days |
| Days Payable |
| Cash Conversion Cycle |
| Working Capital Days |
| ROCE % |
Insights
In beta| Mar 2024 | Mar 2025 | |
|---|---|---|
| Hair Care Revenue Mix % of total revenue ・Standalone data |
|
|
| Lip Care Revenue Mix % of total revenue ・Standalone data |
||
| Personal Care & Hygiene Revenue Mix % of total revenue ・Standalone data |
||
| Sales and Marketing Team Size count ・Standalone data |
||
| Skin Care Revenue Mix % of total revenue ・Standalone data |
||
| Total Employees count ・Standalone data |
||
| Number of States Covered count ・Standalone data |
||
| Total Number of Products (SKUs) count ・Standalone data |
||
Extracted by Screener AI
Documents
Announcements
- Closure of Trading Window
-
Disclosuer Under Regulation 30 Of SEBI (LODR) Regulation, 2015
- Approved up to ₹1.5 crore each in Vivriti Vihaan Trust and Neo Income Plus Fund III.
-
Announcement under Regulation 30 (LODR)-Change in Management
- Members approved five-year reappointment of Tarun Gandhi and Anand Gandhi as Managing Directors from January 27, 2027.
- Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
- Shareholder Meeting / Postal Ballot-Outcome of AGM
Annual reports
-
Annual Report 2026
from bse
-
Annual Report 2025
from web
-
Annual Report 2025
from bse
Business Overview:[1][2]
a) AHL focuses on Dermatology, Trichology, and Cosmetology.
b) It creates advanced skincare solutions using dermatological actives, natural ingredients, and specialized techniques.
c) Operates as a dermal-cosmetic developer, collaborating with contract manufacturers, distributors, and third-party developers.
d) Follows an asset-light model, outsourcing testing, manufacturing, and distribution.